Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Research
HIV protease inhibitors are inhibitors but not substrates of BCRP/ABCG2
September 9th, 2004
HIV protease inhibitors are inhibitors of but not substrates of the human breast cancer resistance protein (BCRP/ABCG2. According to published research from the United States, "Breast cancer resistance protein (BCRP) is a recently discovered ATP-binding cassette drug transporter. Hence, the full spectrum of therapeutic agents that interact with BCRP remains to be elucidated. "Because human immunodeficiency virus protease inhibitors (HPIs) are well known P-glycoprotein (P-gp) substrates, and there is an overlap in substrate specificity between P-gp and BCRP, this study was performed to investigate whether HPIs are substrates and/or inhibitors of...
Source: Blood Weekly (2004-09-09)
|
